Published in Mol Divers on November 01, 2006
Vascular endothelial growth factor can signal through platelet-derived growth factor receptors. J Cell Biol (2007) 1.71
VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis. J Exp Med (2009) 1.70
Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer. Br J Cancer (2011) 1.45
Mesenchymal stem cells and neovascularization: role of platelet-derived growth factor receptors. J Cell Mol Med (2007) 1.33
Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer. Cancer Metastasis Rev (2012) 1.31
Multiscale models of angiogenesis. IEEE Eng Med Biol Mag (2009) 1.26
VEGF modulation of retinal pigment epithelium resistance. Exp Eye Res (2007) 1.25
Angiogenesis in implantation. J Assist Reprod Genet (2007) 1.20
Activated forms of VEGF-C and VEGF-D provide improved vascular function in skeletal muscle. Circ Res (2009) 1.14
Predictors of inflammation in response to anthracycline-based chemotherapy for breast cancer. Brain Behav Immun (2007) 1.10
Elongation, proliferation & migration differentiate endothelial cell phenotypes and determine capillary sprouting. BMC Syst Biol (2009) 1.10
VEGF is differentially regulated in multiple myeloma-derived cell lines by norepinephrine. Brain Behav Immun (2007) 1.08
Vascular endothelial growth factor as an anti-angiogenic target for cancer therapy. Curr Drug Targets (2010) 1.07
VEGF expression in patellar tendinopathy: a preliminary study. Clin Orthop Relat Res (2008) 1.05
Placenta growth factor-1 exerts time-dependent stabilization of adherens junctions following VEGF-induced vascular permeability. PLoS One (2011) 1.00
Cellular distribution of vascular endothelial growth factor A (VEGFA) and B (VEGFB) and VEGF receptors 1 and 2 in focal cortical dysplasia type IIB. Acta Neuropathol (2008) 0.92
The Adnectin CT-322 is a novel VEGF receptor 2 inhibitor that decreases tumor burden in an orthotopic mouse model of pancreatic cancer. BMC Cancer (2008) 0.92
Transforming growth factor-β1 downregulates vascular endothelial growth factor-D expression in human lung fibroblasts via the Jun NH2-terminal kinase signaling pathway. Mol Med (2014) 0.89
Interleukin-1 beta increases activity of human endothelial progenitor cells: involvement of PI3K-Akt signaling pathway. Inflammation (2012) 0.88
Circulating lymphangiogenic growth factors in gastrointestinal solid tumors, could they be of any clinical significance? World J Gastroenterol (2008) 0.85
Applications of snake venom components to modulate integrin activities in cell-matrix interactions. Int J Biochem Cell Biol (2013) 0.84
Control of human endometrial stromal cell motility by PDGF-BB, HB-EGF and trophoblast-secreted factors. PLoS One (2013) 0.84
Vascular endothelial growth factor signals through platelet-derived growth factor receptor β in meningiomas in vitro. Br J Cancer (2012) 0.84
VEGFA family isoforms regulate spermatogonial stem cell homeostasis in vivo. Endocrinology (2011) 0.84
Neither expression of VEGF-C/D nor lymph vessel density supports lymphatic invasion as the mechanism responsible for local spread of recurrent salivary pleomorphic adenoma. Virchows Arch (2014) 0.83
Differential expression of vascular endothelial growth factor isoforms and receptor subtypes in the infarcted heart. Int J Cardiol (2012) 0.83
Poly-γ-glutamic acid attenuates angiogenesis and inflammation in experimental colitis. Mediators Inflamm (2013) 0.83
Structural insights into the binding of vascular endothelial growth factor-B by VEGFR-1(D2): recognition and specificity. J Biol Chem (2010) 0.83
Expression of vascular endothelial growth factor receptor-3 mRNA in the developing rat cerebellum. Cell Mol Neurobiol (2010) 0.82
Role of VEGF, Nitric Oxide, and Sympathetic Neurotransmitters in the Pathogenesis of Tendinopathy: A Review of the Current Evidences. Front Aging Neurosci (2016) 0.82
Anti-VEGF Agents and Glaucoma Filtering Surgery. J Ophthalmic Vis Res (2013) 0.82
Regulation of signaling interactions and receptor endocytosis in growing blood vessels. Cell Adh Migr (2014) 0.82
Vascular endothelial growth factor-C: its unrevealed role in fibrogenesis. Am J Physiol Heart Circ Physiol (2014) 0.81
Possible prognostic role of IL-17R in osteosarcoma. J Cancer Res Clin Oncol (2007) 0.81
Pharmacological aspects of Vipera xantina palestinae venom. Toxins (Basel) (2011) 0.80
VEGF189 expression is highly related to adaptation of the plateau pika (Ochotona curzoniae) inhabiting high altitudes. High Alt Med Biol (2013) 0.80
Snake venom Vascular Endothelial Growth Factors (VEGF-Fs) exclusively vary their structures and functions among species. J Biol Chem (2009) 0.79
Design principles for cytokine-neutralizing gels: Cross-linking effects. Acta Biomater (2010) 0.79
Lactate transporters and vascular factors in HPV-induced squamous cell carcinoma of the uterine cervix. BMC Cancer (2014) 0.79
Expressions of VEGF-A and VEGFR-2 in placentae from GDM pregnancies. Reprod Biol Endocrinol (2016) 0.78
Reprogramming energy metabolism and inducing angiogenesis: co-expression of monocarboxylate transporters with VEGF family members in cervical adenocarcinomas. BMC Cancer (2015) 0.78
Serial plasma levels of angiogenic factors in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Korean Circ J (2012) 0.78
Allyl isothiocyanate ameliorates angiogenesis and inflammation in dextran sulfate sodium-induced acute colitis. PLoS One (2014) 0.77
Deprived TLR9 expression in apparently healthy nasal mucosa might trigger polyp-growth in chronic rhinosinusitis patients. PLoS One (2014) 0.77
Vasotrophic regulation of age-dependent hypoxic cerebrovascular remodeling. Curr Vasc Pharmacol (2013) 0.76
Overload and neovascularization of shoulder tendons in volleyball players. BMC Res Notes (2012) 0.75
Vascular endothelial growth factor genotypes and haplotypes contribute to the susceptibility of obstructive sleep apnea syndrome. PLoS One (2014) 0.75
Sex Steroids Modulate Uterine-Placental Vasculature: Implications for Obstetrics and Neonatal Outcomes. Front Physiol (2016) 0.75
An Emerging Role for Angiogenesis in Tendinopathy. Eur Musculoskelet Rev (2009) 0.75
The influence of vascular endothelial growth factor-A and matrix metalloproteinase-2 and -9 in angiogenesis, metastasis, and prognosis of endometrial cancer. Onco Targets Ther (2017) 0.75
Adenovirus serotype 5 hexon mediates liver gene transfer. Cell (2008) 5.00
A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2. Blood (2005) 2.90
Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans. Pharmacogenet Genomics (2006) 2.66
Involvement of nuclear factor-kappaB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy. Circulation (2002) 2.50
Unified mode of centromeric protection by shugoshin in mammalian oocytes and somatic cells. Nat Cell Biol (2007) 2.13
p38alpha mitogen-activated protein kinase plays a critical role in cardiomyocyte survival but not in cardiac hypertrophic growth in response to pressure overload. Mol Cell Biol (2004) 1.95
Comparison of usefulness of sodium bicarbonate versus sodium chloride to prevent contrast-induced nephropathy in patients undergoing an emergent coronary procedure. Am J Cardiol (2007) 1.71
Cardiac-specific overexpression of sarcolipin inhibits sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA2a) activity and impairs cardiac function in mice. Proc Natl Acad Sci U S A (2004) 1.63
Podoplanin-rich stromal networks induce dendritic cell motility via activation of the C-type lectin receptor CLEC-2. Immunity (2012) 1.50
Coagulation factor X shields adenovirus type 5 from attack by natural antibodies and complement. Nat Med (2013) 1.45
Sporadic amyotrophic lateral sclerosis: two pathological patterns shown by analysis of distribution of TDP-43-immunoreactive neuronal and glial cytoplasmic inclusions. Acta Neuropathol (2008) 1.39
Neuropathology with clinical correlations of sporadic amyotrophic lateral sclerosis: 102 autopsy cases examined between 1962 and 2000. Brain Pathol (2003) 1.36
Mitochondria-related male infertility. Proc Natl Acad Sci U S A (2006) 1.32
The antioxidant N-2-mercaptopropionyl glycine attenuates left ventricular hypertrophy in in vivo murine pressure-overload model. J Am Coll Cardiol (2002) 1.28
Structure and function of snake venom cysteine-rich secretory proteins. Toxicon (2004) 1.26
Crystal structure of Mg2+- and Ca2+-bound Gla domain of factor IX complexed with binding protein. J Biol Chem (2003) 1.22
Cerebellar involvement in progressive supranuclear palsy: A clinicopathological study. Mov Disord (2009) 1.22
Cloning and characterization of novel snake venom proteins that block smooth muscle contraction. Eur J Biochem (2002) 1.16
Wide distribution of cysteine-rich secretory proteins in snake venoms: isolation and cloning of novel snake venom cysteine-rich secretory proteins. Arch Biochem Biophys (2003) 1.11
Crystal structure of trimestatin, a disintegrin containing a cell adhesion recognition motif RGD. J Mol Biol (2003) 1.10
RNA interference during spermatogenesis in mice. Dev Biol (2005) 1.08
Crystal structure of a CRISP family Ca2+ -channel blocker derived from snake venom. J Mol Biol (2005) 1.07
Expression and radiation-induced phosphorylation of histone H2AX in mammalian cells. J Radiat Res (2003) 1.03
Sporadic amyotrophic lateral sclerosis of long duration is associated with relatively mild TDP-43 pathology. Acta Neuropathol (2008) 1.03
Crystal structure of von Willebrand factor A1 domain complexed with snake venom, bitiscetin: insight into glycoprotein Ibalpha binding mechanism induced by snake venom proteins. J Biol Chem (2003) 1.02
Promotion of liver and lung tumorigenesis in DEN-treated cytoglobin-deficient mice. Am J Pathol (2011) 1.02
Purification and cloning of toxins from elapid venoms that target cyclic nucleotide-gated ion channels. Biochemistry (2002) 0.99
A new gene structure of the disintegrin family: a subunit of dimeric disintegrin has a short coding region. Biochemistry (2002) 0.96
Influence of coagulation factor x on in vitro and in vivo gene delivery by adenovirus (Ad) 5, Ad35, and chimeric Ad5/Ad35 vectors. Mol Ther (2009) 0.95
Rad18 is required for long-term maintenance of spermatogenesis in mouse testes. Mech Dev (2008) 0.93
Prediction of sudden death in patients with mild-to-moderate chronic heart failure by using cardiac iodine-123 metaiodobenzylguanidine imaging. Heart (2007) 0.93
Structures of pseudechetoxin and pseudecin, two snake-venom cysteine-rich secretory proteins that target cyclic nucleotide-gated ion channels: implications for movement of the C-terminal cysteine-rich domain. Acta Crystallogr D Biol Crystallogr (2008) 0.93
Damage-induced neuronal endopeptidase is critical for presynaptic formation of neuromuscular junctions. J Neurosci (2010) 0.92
Prevention of contrast-induced nephropathy by bolus injection of sodium bicarbonate in patients with chronic kidney disease undergoing emergent coronary procedures. Am J Cardiol (2011) 0.90
Venous congestive myelopathy: three autopsy cases showing a variety of clinicopathologic features. Neuropathology (2008) 0.90
Crystal structures of novel vascular endothelial growth factors (VEGF) from snake venoms: insight into selective VEGF binding to kinase insert domain-containing receptor but not to fms-like tyrosine kinase-1. J Biol Chem (2004) 0.89
Snake venom vascular endothelial growth factors (VEGFs) exhibit potent activity through their specific recognition of KDR (VEGF receptor 2). J Biol Chem (2003) 0.88
Snake venom components affecting blood coagulation and the vascular system: structural similarities and marked diversity. Curr Pharm Des (2007) 0.88
Long-term effect of atorvastatin on neurohumoral activation and cardiac function in patients with chronic heart failure: a prospective randomized controlled study. Am Heart J (2007) 0.87
Lung carcinoma metastasis presenting as a pineal region tumor. Neuropathology (2003) 0.87
The vascular endothelial growth factor VEGF165 induces perlecan synthesis via VEGF receptor-2 in cultured human brain microvascular endothelial cells. Biochim Biophys Acta (2006) 0.86
Effects of the N/L-type calcium channel blocker cilnidipine on nephropathy and uric acid metabolism in hypertensive patients with chronic kidney disease (J-CIRCLE study). J Clin Hypertens (Greenwich) (2014) 0.85
Augmentation of vascular permeability of VEGF is enhanced by KDR-binding proteins. Biochem Biophys Res Commun (2007) 0.85
gamma-Carboxyglutamic acid content of hepatocellular carcinoma-associated des-gamma-carboxy prothrombin. Biochim Biophys Acta (2002) 0.84
Depletion of medullary serotonergic neurons in patients with multiple system atrophy who succumbed to sudden death. Brain (2009) 0.84
Alveolar epithelial CNGA1 channels mediate cGMP-stimulated, amiloride-insensitive, lung liquid absorption. Pflugers Arch (2011) 0.84
Crystal structure of EMS16 in complex with the integrin alpha2-I domain. J Mol Biol (2004) 0.84
Identification of vascular endothelial growth factor receptor-binding protein in the venom of eastern cottonmouth. A new role of snake venom myotoxic Lys49-phospholipase A2. J Biol Chem (2005) 0.83
Role of advanced glycation end products and growth factors in peritoneal dysfunction in CAPD patients. Am J Kidney Dis (2003) 0.83
Calpain protects the heart from hemodynamic stress. J Biol Chem (2011) 0.82
Early repolarization pattern associated with sudden cardiac death: long-term follow-up in patients with chronic heart failure. J Cardiovasc Electrophysiol (2013) 0.82
Transduction of liver metastases after intravenous injection of Ad5/35 or Ad35 vectors with and without factor X-binding protein pretreatment. Hum Gene Ther (2009) 0.81
pH-Dependent structural changes at Ca(2+)-binding sites of coagulation factor IX-binding protein. J Mol Biol (2005) 0.81
Characterization of a monoclonal antibody B1 that recognizes phosphorylated Ser-158 in the activation peptide region of human coagulation factor IX. J Biol Chem (2006) 0.81
Usefulness of cardiac iodine-123 meta-iodobenzylguanidine imaging to improve prognostic power of Seattle heart failure model in patients with chronic heart failure. Am J Cardiol (2011) 0.80
p53 Protein interacts specifically with the meiosis-specific mammalian RecA-like protein DMC1 in meiosis. Carcinogenesis (2004) 0.80
Structural divergence of cysteine-rich secretory proteins in snake venoms. J Biochem (2008) 0.80
Structural characterization of EMS16, an antagonist of collagen receptor (GPIa/IIa) from the venom of Echis multisquamatus. Biochemistry (2003) 0.79
Control of radiosensitivity of F9 mouse teratocarcinoma cells by regulation of histone H2AX gene expression using a tetracycline turn-off system. Cancer Res (2004) 0.79
Catalytically inactive phospholipase A2 homologue binds to vascular endothelial growth factor receptor-2 via a C-terminal loop region. Biochem J (2008) 0.79
Snake venom Vascular Endothelial Growth Factors (VEGF-Fs) exclusively vary their structures and functions among species. J Biol Chem (2009) 0.79
Spinocerebellar ataxia type 2 (SCA2) is associated with TDP-43 pathology. Acta Neuropathol (2011) 0.79
Identification of the heparin-binding region of snake venom vascular endothelial growth factor (VEGF-F) and its blocking of VEGF-A165. Biochemistry (2005) 0.79
Localization of heparin- and neuropilin-1-recognition sites of viral VEGFs. Biochem Biophys Res Commun (2006) 0.78
Sodium bicarbonate improves long-term clinical outcomes compared with sodium chloride in patients with chronic kidney disease undergoing an emergent coronary procedure. Circ J (2008) 0.78
Alteration of midkine expression in the ischemic brain of humans. J Neurol Sci (2002) 0.78
Inter-individual differences in baseline coagulation activities and their implications for international normalized ratio control during warfarin initiation therapy. Clin Pharmacokinet (2012) 0.78
Survival motor neuron (SMN) protein in the spinal anterior horn cells of patients with sporadic amyotrophic lateral sclerosis. Brain Res (2010) 0.78
Crystallization and preliminary X-ray diffraction analyses of pseudechetoxin and pseudecin, two snake-venom cysteine-rich secretory proteins that target cyclic nucleotide-gated ion channels. Acta Crystallogr Sect F Struct Biol Cryst Commun (2005) 0.78
Induction of instability of p34(cdc2) expression by treatment with cisplatin (CDDP) in mouse teratocarcinoma F9 cells. Cancer Lett (2002) 0.78
Widespread ischemic brain lesions caused by vasculopathy associated with neurofibromatosis type 1. Neuropathology (2010) 0.78
Specific distribution of VEGF-F in Viperinae snake venoms: isolation and characterization of a VGEF-F from the venom of Daboia russelli siamensis. Arch Biochem Biophys (2005) 0.77
Increased intraatrial conduction abnormality assessed by P-wave signal-averaged electrocardiogram in patients with Brugada syndrome. Pacing Clin Electrophysiol (2011) 0.77
Clinical significance of cerebrospinal fluid inhibitory titers of antibiotics, based on pharmacokinetic/pharmacodynamic parameters, in the treatment of bacterial meningitis. J Infect Chemother (2009) 0.77
Crystallization and preliminary crystallographic studies of dimeric disintegrins from the venom of two Agkistrodon snakes. Acta Crystallogr D Biol Crystallogr (2001) 0.77
Age- and gender-related differences of plasma prothrombin activity levels. Thromb Haemost (2007) 0.77
Characterization and preliminary crystallographic studies of EMS16, an antagonist of collagen receptor (GPIa/IIa) from the venom of Echis multisquamatus. J Biochem (2003) 0.77
Anticoagulant mechanism of factor IX/factor X-binding protein isolated from the venom of Trimeresurus flavoviridis. J Biochem (2008) 0.76
Mutations in autolytic loop-2 and at Asp554 of human prothrombin that enhance protein C activation by meizothrombin. J Biol Chem (2003) 0.76
C-terminal heparin-binding peptide of snake venom VEGF specifically blocks VEGF-stimulated endothelial cell proliferation. Pathophysiol Haemost Thromb (2005) 0.76
Prothrombin activation during carbon tetrachloride-induced acute liver injury in mice. Thromb Res (2002) 0.76
Immunohistochemical detection of an AGE, a ligand for macrophage receptor, in peritoneum of CAPD patients. Kidney Int Suppl (2003) 0.76
Effects of chemotherapy on the brain in childhood: diffusion tensor imaging of subtle white matter damage. Neuroradiology (2013) 0.76
Delayed onset acute renal failure associated with Amanita pseudoporphyria Hongo ingestion. Intern Med (2003) 0.76
VEGF-A and VEGF-F evoke distinct changes in vascular ultrastructure. Biochem Biophys Res Commun (2009) 0.76
Widespread vertebral and epidural venous plexus metastasis of prostatic carcinoma presenting wedge-shaped radial lesions in the spinal cord. Neuropathology (2003) 0.75
Schnitzler syndrome complicated by membranous nephropathy. Clin Nephrol (2012) 0.75
Letter to the editor concerning the article "Renal endarteritis with acute endocapillary proliferative glomerulonephritis" by Kawaguchi et al., Clin Nephrol. 2012; 77: 151-155 and authors response. Clin Nephrol (2012) 0.75
Renal sclerosing peritubular nodules in a patient with neurofibromatosis type 2: A case report with immunohistochemical and electron microscopic studies. Hum Pathol (2010) 0.75
Crystallization and preliminary X-ray analysis of coagulation factor IX-binding protein from habu snake venom at pH 6.5 and 4.6. Acta Crystallogr Sect F Struct Biol Cryst Commun (2004) 0.75
Identification and localization of heparin-binding region of snake venom VEGF and its blocking of VEGF-A165. Pathophysiol Haemost Thromb (2005) 0.75
Re-evaluation of M-LAO, L-amino acid oxidase, from the venom of Gloydius blomhoffi as an anticoagulant protein. J Biochem (2009) 0.75
A defect in collagen receptor-Ca2+ signaling system in platelets from cattle with Chediak-Higashi syndrome. Thromb Haemost (2002) 0.75
Separate CNS lesions involving the brainstem and spinal cord in a 47-year-old man. Neuropathology (2007) 0.75
Kidney enhancement on X-rays following emergency percutaneous coronary procedure predicts poor short- and long-term clinical outcomes. Circ J (2012) 0.75
[History of mesangiolysis, with special reference to research in Japan]. Nihon Jinzo Gakkai Shi (2003) 0.75
Mammalian carboxylesterase (CES) releases GPI-anchored proteins from the cell surface upon lipid raft fluidization. Biol Chem (2012) 0.75
Atorvastatin therapy associated with improvement in left ventricular remodeling in a case of idiopathic dilated cardiomyopathy. Am J Med Sci (2006) 0.75